Ferd Private Equity (FPE I) has listed Pronova BioPharma (previously Pronova Biocare), a Norwegian manufacturer of Omega-3 pharmaceutical products, on the Oslo Stock Exchange for an offer price of NOK 23 per share. The total offer size is NOK 2.7bn (including an over-allotment option), and based on the set offer price, the company will have a market capitalisation of NOK 6.9bn (EUR 900m). Prior to the listing, Ferd held 93% of the shares, but at the completion of the offer, the investor will hold approximately 58.3% of the shareholding. Carnegie and UBS acted as joint global coordinator and joint bookrunners for the offering.
Polish buyout firm Abris Capital Partners has signed an agreement to sell its stake in Polish locomotive lessor Cargounit, also known as Industrial Division, to Three Seas Investment Fund (3SIIF).
Amplify IV targets seed and series-A rounds, while Amplify Select makes follow-on investments in existing portfolio companies
GP had previously made an offer of SEK 70 per share, which was later increased to SEK 72 per share
Company intends to boost its production capability, bolster its international expansion and pursue a buy-and-build strategy